3/18
08:03 am
rytm
Rhythm Pharmaceuticals (RYTM) had its price target lowered by HC Wainwright from $110.00 to $100.00. They now have a "buy" rating on the stock.
Medium
Report
Rhythm Pharmaceuticals (RYTM) had its price target lowered by HC Wainwright from $110.00 to $100.00. They now have a "buy" rating on the stock.
3/17
11:39 am
rytm
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Citigroup Inc. from $136.00 to $131.00. They now have a "buy" rating on the stock.
Low
Report
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Citigroup Inc. from $136.00 to $131.00. They now have a "buy" rating on the stock.
3/17
10:46 am
rytm
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Royal Bank Of Canada from $140.00 to $130.00. They now have an "outperform" rating on the stock.
Low
Report
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Royal Bank Of Canada from $140.00 to $130.00. They now have an "outperform" rating on the stock.
3/17
09:46 am
rytm
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Citizens Jmp from $176.00 to $152.00. They now have a "market outperform" rating on the stock.
Low
Report
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Citizens Jmp from $176.00 to $152.00. They now have a "market outperform" rating on the stock.
3/17
08:25 am
rytm
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Bank of America Corporation from $145.00 to $139.00. They now have a "buy" rating on the stock.
Low
Report
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Bank of America Corporation from $145.00 to $139.00. They now have a "buy" rating on the stock.
3/17
08:01 am
rytm
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Needham & Company LLC from $139.00 to $130.00. They now have a "buy" rating on the stock.
Medium
Report
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Needham & Company LLC from $139.00 to $130.00. They now have a "buy" rating on the stock.
3/17
08:01 am
rytm
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Morgan Stanley from $150.00 to $136.00. They now have an "overweight" rating on the stock.
Medium
Report
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Morgan Stanley from $150.00 to $136.00. They now have an "overweight" rating on the stock.
3/16
04:33 pm
rytm
Rhythm Pharmaceuticals Announces Topline Results from Phase 3 EMANATE Trial [Yahoo! Finance]
Medium
Report
Rhythm Pharmaceuticals Announces Topline Results from Phase 3 EMANATE Trial [Yahoo! Finance]
3/16
04:01 pm
rytm
Rhythm Pharmaceuticals Announces Topline Results from Phase 3 EMANATE Trial
Low
Report
Rhythm Pharmaceuticals Announces Topline Results from Phase 3 EMANATE Trial
3/16
01:18 pm
rytm
Rhythm Pharmaceuticals: Rare Genetic Obesity Player With Upcoming PDUFA [Seeking Alpha]
Low
Report
Rhythm Pharmaceuticals: Rare Genetic Obesity Player With Upcoming PDUFA [Seeking Alpha]
3/16
07:38 am
rytm
Rhythm Pharmaceuticals Q4 Beat Sets Stage For March 20th PDUFA Decision [Seeking Alpha]
Low
Report
Rhythm Pharmaceuticals Q4 Beat Sets Stage For March 20th PDUFA Decision [Seeking Alpha]
3/12
09:10 am
rytm
Rhythm Pharmaceuticals (RYTM) was given a new $143.00 price target by Telsey Advisory Group.
Low
Report
Rhythm Pharmaceuticals (RYTM) was given a new $143.00 price target by Telsey Advisory Group.
3/12
08:07 am
rytm
Rhythm Pharmaceuticals (RYTM) had its "overweight" rating reaffirmed by Wells Fargo & Company.
Low
Report
Rhythm Pharmaceuticals (RYTM) had its "overweight" rating reaffirmed by Wells Fargo & Company.
3/3
06:06 pm
rytm
Rhythm Pharmaceuticals (RYTM) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Low
Report
Rhythm Pharmaceuticals (RYTM) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
3/3
08:54 am
rytm
Rhythm Pharmaceuticals price target lowered to $110 from $125 at H.C. Wainwright [Yahoo! Finance]
Medium
Report
Rhythm Pharmaceuticals price target lowered to $110 from $125 at H.C. Wainwright [Yahoo! Finance]
3/2
02:27 pm
rytm
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Canaccord Genuity Group Inc. from $141.00 to $140.00. They now have a "buy" rating on the stock.
Low
Report
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Canaccord Genuity Group Inc. from $141.00 to $140.00. They now have a "buy" rating on the stock.
3/2
09:27 am
rytm
Rhythm Pharmaceuticals (RYTM) had its price target lowered by HC Wainwright from $125.00 to $110.00. They now have a "buy" rating on the stock.
Low
Report
Rhythm Pharmaceuticals (RYTM) had its price target lowered by HC Wainwright from $125.00 to $110.00. They now have a "buy" rating on the stock.
3/1
02:36 pm
rytm
A Look At Rhythm Pharmaceuticals (RYTM) Valuation After Recent Pullback In Share Price [Yahoo! Finance]
Low
Report
A Look At Rhythm Pharmaceuticals (RYTM) Valuation After Recent Pullback In Share Price [Yahoo! Finance]
3/1
12:54 pm
rytm
Rhythm Pharmaceuticals Announces Additional Positive Data from Phase 3 TRANSCEND trial of Setmelanotide in Patients with Acquired Hypothalamic Obesity [Yahoo! Finance]
Low
Report
Rhythm Pharmaceuticals Announces Additional Positive Data from Phase 3 TRANSCEND trial of Setmelanotide in Patients with Acquired Hypothalamic Obesity [Yahoo! Finance]
3/1
12:30 pm
rytm
Rhythm Pharmaceuticals Announces Additional Positive Data from Phase 3 TRANSCEND trial of Setmelanotide in Patients with Acquired Hypothalamic Obesity
Low
Report
Rhythm Pharmaceuticals Announces Additional Positive Data from Phase 3 TRANSCEND trial of Setmelanotide in Patients with Acquired Hypothalamic Obesity
2/27
07:03 pm
rytm
Rhythm Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Low
Report
Rhythm Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/27
11:41 am
rytm
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Wells Fargo & Company from $145.00 to $136.00. They now have an "overweight" rating on the stock.
Low
Report
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Wells Fargo & Company from $145.00 to $136.00. They now have an "overweight" rating on the stock.
2/27
09:21 am
rytm
Rhythm Pharmaceuticals (RYTM) had its price target raised by Citizens Jmp from $167.00 to $176.00. They now have a "market outperform" rating on the stock.
Medium
Report
Rhythm Pharmaceuticals (RYTM) had its price target raised by Citizens Jmp from $167.00 to $176.00. They now have a "market outperform" rating on the stock.
2/27
08:02 am
rytm
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Needham & Company LLC from $148.00 to $139.00. They now have a "buy" rating on the stock.
Medium
Report
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Needham & Company LLC from $148.00 to $139.00. They now have a "buy" rating on the stock.
2/27
08:02 am
rytm
Rhythm Pharmaceuticals (RYTM) had its price target raised by Guggenheim from $140.00 to $143.00. They now have a "buy" rating on the stock.
Medium
Report
Rhythm Pharmaceuticals (RYTM) had its price target raised by Guggenheim from $140.00 to $143.00. They now have a "buy" rating on the stock.